Chemours Co (CC) stock
CCNYSEChemicals & Allied ProductsFiscal year ends December 31
$12.09−0.09 (-0.74%)
Close on Nov 18, 2026Market cap $1.82BP/E –Yield 4.24%
Chemours net income
Net income is the profit left for shareholders after every expense, interest and tax.
Chemours's net income for the twelve months ending Jun 30, 2026 was -$304.00M. For fiscal 2025 it was -$386.00M, down 659.4% from the year before. The highest annual figure on record is $995.00M in fiscal 2018.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$386.00M | -659.4% |
| FY2024 | Dec 31, 2024 | $69.00M | – |
| FY2023 | Dec 31, 2023 | -$253.00M | -143.8% |
| FY2022 | Dec 31, 2022 | $578.00M | -4.9% |
| FY2021 | Dec 31, 2021 | $608.00M | +177.6% |
| FY2020 | Dec 31, 2020 | $219.00M | – |
| FY2019 | Dec 31, 2019 | -$52.00M | -105.2% |
| FY2018 | Dec 31, 2018 | $995.00M | +33.4% |
| FY2017 | Dec 31, 2017 | $746.00M | +10557.1% |
| FY2016 | Dec 31, 2016 | $7.00M | – |
| FY2015 | Dec 31, 2015 | -$90.00M | -122.5% |
| FY2014 | Dec 31, 2014 | $400.00M | -5.4% |
| FY2013 | Dec 31, 2013 | $423.00M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$274.00M | – |
| Q1 FY2026 | Mar 31, 2026 | -$29.00M | – |
| Q4 FY2025 | Dec 31, 2025 | -$47.00M | – |
| Q3 FY2025 | Sep 30, 2025 | $46.00M | – |
| Q2 FY2025 | Jun 30, 2025 | -$380.00M | -733.3% |
| Q1 FY2025 | Mar 31, 2025 | -$5.00M | -109.3% |
| Q4 FY2024 | Dec 31, 2024 | -$11.00M | – |
| Q3 FY2024 | Sep 30, 2024 | -$32.00M | -366.7% |
| Q2 FY2024 | Jun 30, 2024 | $60.00M | – |
| Q1 FY2024 | Mar 31, 2024 | $54.00M | -62.8% |
| Q4 FY2023 | Dec 31, 2023 | -$18.00M | – |
| Q3 FY2023 | Sep 30, 2023 | $12.00M | -95.0% |
| Q2 FY2023 | Jun 30, 2023 | -$376.00M | -287.1% |
| Q1 FY2023 | Mar 31, 2023 | $145.00M | -38.0% |
| Q4 FY2022 | Dec 31, 2022 | -$97.00M | -141.6% |
| Q3 FY2022 | Sep 30, 2022 | $240.00M | +12.1% |
| Q2 FY2022 | Jun 30, 2022 | $201.00M | +204.5% |
| Q1 FY2022 | Mar 31, 2022 | $234.00M | +143.8% |
| Q4 FY2021 | Dec 31, 2021 | $233.00M | +1126.3% |
| Q3 FY2021 | Sep 30, 2021 | $214.00M | +181.6% |
| Q2 FY2021 | Jun 30, 2021 | $66.00M | +175.0% |
| Q1 FY2021 | Mar 31, 2021 | $96.00M | -4.0% |
| Q4 FY2020 | Dec 31, 2020 | $19.00M | – |
| Q3 FY2020 | Sep 30, 2020 | $76.00M | 0.0% |
| Q2 FY2020 | Jun 30, 2020 | $24.00M | -75.0% |
| Q1 FY2020 | Mar 31, 2020 | $100.00M | +6.4% |
| Q4 FY2019 | Dec 31, 2019 | -$317.00M | -323.2% |
| Q3 FY2019 | Sep 30, 2019 | $76.00M | -72.4% |
| Q2 FY2019 | Jun 30, 2019 | $96.00M | -65.8% |
| Q1 FY2019 | Mar 31, 2019 | $94.00M | -68.4% |
| Q4 FY2018 | Dec 31, 2018 | $142.00M | -37.7% |
| Q3 FY2018 | Sep 30, 2018 | $275.00M | +32.9% |
| Q2 FY2018 | Jun 30, 2018 | $281.00M | +74.5% |
| Q1 FY2018 | Mar 31, 2018 | $297.00M | +98.0% |
| Q4 FY2017 | Dec 31, 2017 | $228.00M | – |
| Q3 FY2017 | Sep 30, 2017 | $207.00M | +1.5% |
| Q2 FY2017 | Jun 30, 2017 | $161.00M | – |
| Q1 FY2017 | Mar 31, 2017 | $150.00M | – |
| Q4 FY2016 | Dec 31, 2016 | -$230.00M | – |
| Q3 FY2016 | Sep 30, 2016 | $204.00M | – |
See a number that looks wrong?